(Q46704299)

English

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

scientific article published in January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

multiple sclerosis

0 references

0 references

Cristina Ramo-Tello

object named as

C Ramo-Tello

4

0 references

author name string

V Devonshire

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

Y Lapierre

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

R Macdonell

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

F Patti

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

P Fontoura

6

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

L Suchet

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

R Hyde

8

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

I Balla

9

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

E M Frohman

10

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

B C Kieseier

11

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

GAP Study Group

12

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

publication date

1 January 2011

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

European Journal of Neurology

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

18

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

69-77

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Long-term interferon-beta treatment for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Predicting treatment discontinuation among patients with multiple sclerosis: application of the transtheoretical model of change

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Factors leading patients to discontinue multiple sclerosis therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six months

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Factors that influence adherence with disease-modifying therapy in MS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Memory impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Depression and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

21 January 2018

Identifiers

10.1111/J.1468-1331.2010.03110.X

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/20561039

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46704299&oldid=2127612886"